Article
Monoclonal antibodies targeting surface exposed epitopes of <i>Candida albicans</i> cell wall proteins confer <i>in vivo</i> protection in an infection model
2021-09-29
Abstract excerpt
MAb based immunotherapies targeting systemic and deep-seated fungal infections are still in their early stages of development with currently no licensed antifungal mAbs available for patients at risk. The cell wall glycoproteins of Candida albicans are of particular interest as potential targets for therapeutic antibody generation due to their extracellular location and key involvement in fungal pathogenesis. Her...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d93dc964-85a2-547d-b0a1-a34fedf053d5
- DOI
- 10.1101/2021.09.29.462385
